FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
AREDIA
pamidronate disodium
LOE Approaching
Novartis
INJECTION · INJECTABLE
moderatesevere hypercalcemia associated with malignancy+6
1998
NDA
30/100
AREDIA
pamidronate disodium
LOE Approaching
Novartis
INJECTION · INJECTABLE
moderatesevere hypercalcemia associated with malignancy+6
1991
NDA
30/100
ARESTIN
minocycline hydrochloride
LOE Approaching
DENTAL · POWDER, EXTENDED RELEASE
2001
NDA
30/100
ARFONAD
trimethaphan camsylate
LOE Approaching
Roche
INJECTION · INJECTABLE
1954
NDA
30/100
ARGATROBAN
argatroban
LOE Approaching
Novartis
INJECTION · INJECTABLE
For prophylaxis or treatment of thrombosis
2000
NDA
30/100
ARGATROBAN
argatroban
Peak
Hikma
INJECTION · INJECTABLE
For prophylaxis or treatment of thrombosis
2012
NDA
30/100
ARGATROBAN
argatroban
Peak
Fresenius Kabi
INJECTION · INJECTABLE
2015
NDA
30/100
ARGATROBAN IN 0.9% SODIUM CHLORIDE
argatroban
Peak
Teva
INTRAVENOUS · INJECTABLE
For prophylaxis or treatment of thrombosis
2014
NDA
30/100
ARGATROBAN IN DEXTROSE
argatroban
LOE Approaching
Novartis
INTRAVENOUS · SOLUTION
For prophylaxis or treatment of thrombosis
2011
NDA
30/100
ARGATROBAN IN SODIUM CHLORIDE
argatroban
Peak
Accord Biopharma
INTRAVENOUS · SOLUTION
For prophylaxis or treatment of thrombosis
2021
NDA
30/100
ARGATROBAN IN SODIUM CHLORIDE
argatroban
LOE Approaching
INTRAVENOUS · INJECTABLE
For prophylaxis or treatment of thrombosis
2011
NDA
30/100
ARGATROBAN IN SODIUM CHLORIDE
argatroban
Peak
INTRAVENOUS · SOLUTION
For prophylaxis or treatment of thrombosis
2018
NDA
30/100
ARICEPT
donepezil hydrochloride
LOE Approaching
Eisai
ORAL · TABLET
dementia of the Alzheimer's typeAlzheimer's disease
1996
NDA
30/100
ARICEPT
donepezil hydrochloride
LOE Approaching
Eisai
ORAL · SOLUTION
dementia of the Alzheimer's typeAlzheimer's disease
2004
NDA
30/100
ARICEPT ODT
donepezil hydrochloride
LOE Approaching
Eisai
ORAL · TABLET, ORALLY DISINTEGRATING
dementia of the Alzheimer's typeAlzheimer's disease
2004
NDA
30/100
ARIDOL
mannitol
LOE Approaching
INHALATION · POWDER
asthma
2010
NDA
30/100
ARIDOL KIT
mannitol
LOE Approaching
INHALATION · POWDER
asthma
2010
NDA
30/100
ARIMIDEX
anastrozole
LOE Approaching
AstraZeneca
ORAL · TABLET
advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapybreast cancer
2008
SMNDA
30/100
ARIMIDEX
anastrozole
LOE Approaching
ANI Pharmaceuticals
ORAL · TABLET
advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapybreast cancer
1995
SMNDA
30/100
ARISTOCORT
triamcinolone diacetate
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
1959
NDA
30/100
ARISTOCORT
triamcinolone diacetate
LOE Approaching
Astellas
ORAL · SYRUP
1959
NDA
30/100
ARISTOCORT
triamcinolone
LOE Approaching
Astellas
ORAL · TABLET
1957
NDA
30/100
ARISTOCORT
triamcinolone diacetate
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
1961
NDA
30/100
ARISTOSPAN
triamcinolone hexacetonide
LOE Approaching
INJECTION · INJECTABLE
1969
NDA
30/100
← PreviousPage 15 of 277Next →